Cargando…
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
PURPOSE: B-cell lymphoma 2 (BCL2) is an antiapoptosis protein and an important clinical breast cancer prognostic marker. As the role of BCL2 is dependent on the estrogen receptor (ER) status, this effect might differ according to molecular subtypes. The aim of this study was to evaluate the relation...
Autores principales: | Eom, Yong Hwa, Kim, Hyung Suk, Lee, Ahwon, Song, Byung Joo, Chae, Byung Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053309/ https://www.ncbi.nlm.nih.gov/pubmed/27721874 http://dx.doi.org/10.4048/jbc.2016.19.3.252 |
Ejemplares similares
-
Sparganosis of the Unilateral Breast: A Case Report
por: Kim, Hyung Suk, et al.
Publicado: (2017) -
Expression of AIB1 protein as a prognostic factor in breast cancer
por: Lee, Kyungji, et al.
Publicado: (2011) -
Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy
por: Chae, Byung Joo, et al.
Publicado: (2009) -
Improved Model for Predicting Axillary Response to Neoadjuvant Chemotherapy in Patients with Clinically Node-Positive Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2017) -
Imaging features of complex sclerosing lesions of the breast
por: Myong, Joo Hwa, et al.
Publicado: (2014)